Amrutanjan Health Care Limited — Board Meeting, 03-02-2026: Outcome of Board Meeting
03-02-2026 | 05:16 pm
03-02-2026 | 05:16 pm
Amrutanjan's Board approved financial results for the quarter and nine months ended Dec 31, 2025. Q3 revenue was ₹141.04 Cr, with PAT at ₹19.45 Cr. A second interim dividend of Re.1 per share was also declared.
No comments yet. Be the first to comment!
